New generation intraocular lenses (IOLs) are changing the game for patients seeking more spectacle independence, with reduced visual disturbances. Insight...
Read moreRecent study results have provided real-world evidence supporting the effectiveness, tolerability, and safety profile of Ikervis, a 0.1% ciclosporin eye...
Read moreUS biopharmaceutical company Iveric Bio has released new data for its avacincaptad pegol (ACP) therapy for geographic atrophy (GA), which...
Read moreRayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, has announced the launch of...
Read moreAt the completion of this article, the reader should be able to improve their management of patients with glaucoma. Including:...
Read moreAt the completion of this article, the reader should be able to improve their glaucoma management. Including: • Understand the...
Read moreFour international experts provide guidance in a series of clinically-relevant perspectives on dry eye disease treatment procedures in Issue 70...
Read moreSpecsavers has hit a major milestone in its efforts to find undetected glaucoma in Australia, ensuring patients now have more...
Read moreGlaucoma specialist and medical geneticist DR JANEY WIGGS revealed two new genes in juvenile early-onset glaucoma and dissected the value...
Read moreWith the average life expectancy at initial glaucoma diagnosis being up to 13 years, patients require a sustainable first line...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited